Showing results (111-120 of 127) with videos related to
Sort By:
Pageof 13
Diabetes Care|May 6, 2026
Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody-Positive AdultsErin L Templeman, Nick Thomas, Susan Martin, et al.Medrxiv : the Preprint Server for Health Sciences|October 9, 2023
Clinical prediction models combining routine clinical measures identify participants with youth-onset diabetes who maintain insulin secretion in the range associated with type 2 diabetes: The SEARCH for Diabetes in Youth StudyAngus G Jones, Beverley M Shields, Richard A Oram, et al.Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Accounting for age-related increases in HbA1c more accurately quantifies risk of Type 1 Diabetes progression in islet autoantibody-positive adultsErin L Templeman, Nick Thomas, Susan Martin, et al.Diabetes|December 10, 2025
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and ProgressionTaylor M Triolo, Jay M Sosenko, David Cuthbertson, et al.Diabetes/Metabolism Research and Reviews|October 27, 2023
Diabetes Study of Children of Diverse Ethnicity and Race: Study designMaria J Redondo, Kylie K Harrall, Deborah H Glueck, et al.Diabetes Care|January 22, 2024
Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth StudyAngus G Jones, Beverley M Shields, Richard A Oram, et al.Diabetes Care|April 15, 2024
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy TrialsLaura M Jacobsen, David Cuthbertson, Brian N Bundy, et al.Medrxiv : the Preprint Server for Health Sciences|August 12, 2025
The impact of ancestry on performance of type 1 diabetes genetic risk scores: high discrimination performance is maintained in African ancestry populations, but population specific thresholds may improve risk predictionSteven Squires, Jean Claude Katte, Dana Dabelea, et al.Communications Medicine|October 4, 2023
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic reviewLaura M Jacobsen, Jennifer L Sherr, Elizabeth Considine, et al.The Journal of Clinical Endocrinology and Metabolism|March 11, 2026
Relative maternal protection against type 1 diabetes: a combined analysis of five observational studiesLowri A Allen, Peter N Taylor, Annelie Carlsson, et al.Pageof 13